Sodium Chloride Symporter Inhibitors

"Sodium Chloride Symporter Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents that inhibit SODIUM CHLORIDE SYMPORTERS. They act as DIURETICS. Excess use is associated with HYPOKALEMIA.

Descriptor ID	D049993
MeSH Number(s)	D27.505.519.562.812 D27.505.696.560.500.863
Concept/Terms	Sodium Chloride Symporter Inhibitors Sodium Chloride Symporter Inhibitors Sodium Chloride Cotransporter Inhibitors Thiazide Sensitive NaCl Cotransporter Inhibitors Diuretics, Thiazide Diuretics, Thiazide Thiazide Diuretics Benzothiadiazine Diuretics Diuretics, Benzothiadiazine Potassium Depleting Diuretics Potassium Depleting Diuretics Diuretics, Potassium Depleting

Below are MeSH descriptors whose meaning is more general than "Sodium Chloride Symporter Inhibitors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Molecular Mechanisms of Pharmacological Action [D27.505.519]
Membrane Transport Modulators [D27.505.519.562]
Sodium Chloride Symporter Inhibitors [D27.505.519.562.812]
Physiological Effects of Drugs [D27.505.696]
Natriuretic Agents [D27.505.696.560]
Diuretics [D27.505.696.560.500]
Sodium Chloride Symporter Inhibitors [D27.505.696.560.500.863]

Below are MeSH descriptors whose meaning is related to "Sodium Chloride Symporter Inhibitors".

Below are MeSH descriptors whose meaning is more specific than "Sodium Chloride Symporter Inhibitors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Sodium Chloride Symporter Inhibitors" by people in this website by year, and whether "Sodium Chloride Symporter Inhibitors" was a major or minor topic of these publications.

Bar chart showing 13 publications over 11 distinct years, with a maximum of 2 publications in 1999 and 2000

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1997	1	0	1
1998	1	0	1
1999	0	2	2
2000	0	2	2
2001	0	1	1
2003	1	0	1
2010	0	1	1
2014	0	1	1
2015	0	1	1
2022	0	1	1

Below are the most recent publications written about "Sodium Chloride Symporter Inhibitors" by people in Profiles.

Sahai SK, Balonov K, Bentov N, Bierle DMM, Browning LM, Cummings KC, Dougan BM, Maxwell M, Merli GJ, Oprea AD, Sweitzer B, Mauck KF, Urman RD. Preoperative Management of Cardiovascular Medications: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement. Mayo Clin Proc. 2022 09; 97(9):1734-1751.

View in: PubMed
Merli GJ, Weitz HH. Web Exclusives. The Consult Guys--Controlling Hypertension: The Pressure Is Killing Me! Ann Intern Med. 2015 06 16; 162(12):CG1.

View in: PubMed
Qaseem A, Dallas P, Forciea MA, Starkey M, Denberg TD. Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2014 Nov 04; 161(9):659-67.

View in: PubMed
Maio V, Gagne JJ. Impact of ALLHAT publication on antihypertensive prescribing patterns in Regione Emilia-Romagna, Italy. J Clin Pharm Ther. 2010 Feb; 35(1):55-61.

View in: PubMed
Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA. 2003 Dec 03; 290(21):2805-16.

View in: PubMed
Stein MS, Flicker L, Scherer SC, Paton LM, O'Brien ML, Walton SC, Chick P, Di Carlantonio M, Zajac JD, Wark JD. Relationships with serum parathyroid hormone in old institutionalized subjects. Clin Endocrinol (Oxf). 2001 May; 54(5):583-92.

View in: PubMed
Zyczynski TM, Leidy NK, Kong BW, Helaszek CT, Michelson EL. Effects of candesartan cilexetil on health-related quality of life in black patients with systemic hypertension in the ABC Trial. Heart Dis. 2000 Nov-Dec; 2(6):400-6.

View in: PubMed
Skolnik NS, Beck JD, Clark M. Combination antihypertensive drugs: recommendations for use. Am Fam Physician. 2000 May 15; 61(10):3049-56.

View in: PubMed
Su JZ, Chen SC, Wu KG, Chen DG, Rui HB, Wang XY, Wang HJ. Effects of perindopril, propranolol, and dihydrochlorothiazide on cardiovascular remodelling in spontaneously hypertensive rats. Zhongguo Yao Li Xue Bao. 1999 Oct; 20(10):923-8.

View in: PubMed
Oparil S, Levine JH, Zuschke CA, Gradman AH, Ripley E, Jones DW, Hardison JD, Cushing DJ, Prasad R, Michelson EL. Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators. Am J Cardiol. 1999 Aug 01; 84(3):289-93.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement